Overexpression of SPHK1 associated with targeted therapy resistance in predicting poor prognosis in renal cell carcinoma
Authors:
- Ji-Ming BaoJBJi-Ming Bao
- Xi ZhiXZXi Zhi
- Hao-Yu YuanHYHao-Yu Yuan
- Tao-Yi ChenTCTao-Yi Chen
- Ming-Kun ChenMCMing-Kun Chen
- Jun-Hao ZhouJZJun-Hao Zhou
- Kang-Yi XueKXKang-Yi Xue
- Jian-Kun YangJYJian-Kun Yang
- Cun-Dong LiuCLCun-Dong Liu
Open Access
- 1 March 2023
- journal article
- research article
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 12 (3) , 572-584
Abstract
Original Article Overexpression of SPHK1 associated with targeted therapy resistance in predicting poor prognosis in renal cell carcinoma Ji-Ming Bao, Xi Zhi, Hao-Yu Yuan, Tao-Yi Chen, Ming-Kun Chen, Jun-Hao Zhou, Kang-Yi Xue, Jian-Kun Yang, Cun-Dong LiuKeywords
This publication has 20 references indexed in Scilit:
- Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinomaJournal of Experimental & Clinical Cancer Research, 2017
- Targeting Signaling Pathways in Cancer Stem Cells for Cancer TreatmentStem Cells International, 2017
- Improvement in survival end points of patients with metastatic renal cell carcinoma through sequential targeted therapyCancer Treatment Reviews, 2016
- Wnt Signaling in Renal Cell CarcinomaCancers, 2016
- Loss of DAB2IP in RCC cells enhances their growth and resistance to mTOR-targeted therapiesOncogene, 2016
- EAU Guidelines on Renal Cell Carcinoma: 2014 UpdateEuropean Urology, 2015
- Anti-S1P Antibody as a Novel Therapeutic Strategy for VEGFR TKI-Resistant Renal CancerClinical Cancer Research, 2015
- Serum and Urine Biomarkers for Human Renal Cell CarcinomaDisease Markers, 2015
- Sphingosine Kinase 1 Overexpression Contributes to Cetuximab Resistance in Human Colorectal Cancer ModelsClinical Cancer Research, 2013
- Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseasesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2006